Ticker
VTGNCompany Name
VISTAGEN THERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Net Cash Flow - Operations | Operating Cash Flow Margin | Revenues |
---|---|---|---|
6/30/2025 | $ -50.07M | -7751.39% | $ 646K |
3/31/2025 | $ -42.1M | -8661.93% | $ 486K |
12/31/2024 | $ -39.23M | -5618.23% | $ 698.3K |
9/30/2024 | $ -33.49M | -3824.08% | $ 875.7K |
6/30/2024 | $ -28.79M | -2966.93% | $ 970.4K |
3/31/2024 | $ -25.81M | -2426.03% | $ 1.06M |
12/31/2023 | $ -26.09M | -2502.98% | $ 1.04M |
9/30/2023 | $ -31.49M | -3884.82% | $ 810.5K |
6/30/2023 | $ -41.64M | 0% | $ -359.7K |
3/31/2023 | $ -49.72M | 0% | $ -227.3K |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
CF - Operations / Revenues
(=) OCF %
OCF % for VISTAGEN THERAPEUTICS INC is calculated as follows: CF - Operations [ $ -8.66M ] / Revenues [ $ 334K ]
(=) OCF % [ -2593.35% ]
Minimum
Mar 31, 2025
Maximum
Jun 30, 2021
Average
Median
filtered constituents | 3.25K |
---|---|
min | -57.27% |
max | 78.12% |
average | 14.35% |
median | 12.67% |
std | 21.14% |